{"id":4429,"date":"2025-11-28T09:24:05","date_gmt":"2025-11-28T06:24:05","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=4429"},"modified":"2025-11-28T09:24:06","modified_gmt":"2025-11-28T06:24:06","slug":"hiv-zor-degil-hic-zor-degil","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=4429","title":{"rendered":"HIV Zor De\u011fil, H\u0130\u00c7 Zor De\u011fil"},"content":{"rendered":"\n<p><strong>1 Aral\u0131k D\u00fcnya AIDS G\u00fcn\u00fc \u00f6ncesinde Gilead T\u00fcrkiye\u2019nin ev sahipli\u011finde d\u00fczenlenen \u201cHIV Zor De\u011fil \/ H\u0130\u00c7 Zor De\u011fil\u201d temal\u0131 bas\u0131n toplant\u0131s\u0131nda uzman hekimler ve sivil toplum temsilcileri bir araya gelerek erken tan\u0131n\u0131n hayati \u00f6nemine dikkat \u00e7ekti. Toplant\u0131da, HIV testine eri\u015fimin kolayla\u015ft\u0131r\u0131lmas\u0131, damgalaman\u0131n azalt\u0131lmas\u0131 ve toplumda a\u00e7\u0131k diyalo\u011fun g\u00fc\u00e7lendirilmesi gerekti\u011fi vurguland\u0131. Payda\u015flar, d\u00fczenli testlerin yayg\u0131nla\u015fmas\u0131n\u0131n hem ki\u015filerin ya\u015fam kalitesini art\u0131raca\u011f\u0131 hem de T\u00fcrkiye\u2019nin HIV kaynakl\u0131 sa\u011fl\u0131k y\u00fck\u00fcn\u00fc azaltaca\u011f\u0131 mesaj\u0131n\u0131 verdi.<\/strong><\/p>\n\n\n\n<p>HIV konusunda fark\u0131ndal\u0131k yaratmak ve erken tan\u0131n\u0131n kritik rol\u00fcne dikkat \u00e7ekmek amac\u0131yla Gilead T\u00fcrkiye ev sahipli\u011finde \u201cHIV Zor De\u011fil \/ H\u0130\u00c7 Zor De\u011fil\u201d temal\u0131 bir bas\u0131n toplant\u0131s\u0131 d\u00fczenlendi. A\u00e7\u0131l\u0131\u015f konu\u015fmas\u0131n\u0131 Gilead T\u00fcrkiye Genel M\u00fcd\u00fcr\u00fc Deepshikha Kiyawat\u2019\u0131n ger\u00e7ekle\u015ftirdi\u011fi toplant\u0131da, enfeksiyon hastal\u0131klar\u0131 uzmanlar\u0131 ve HIV alan\u0131nda \u00e7al\u0131\u015fan sivil toplum kurulu\u015flar\u0131 bir araya geldi. Payda\u015flar, HIV testine eri\u015fimin kolayla\u015ft\u0131r\u0131lmas\u0131, damgalaman\u0131n azalt\u0131lmas\u0131 ve toplumda a\u00e7\u0131k diyalo\u011fun g\u00fc\u00e7lendirilmesi gerekti\u011fini vurgulad\u0131. D\u00fczenli testlerin yayg\u0131nla\u015fmas\u0131n\u0131n hem ki\u015filerin ya\u015fam kalitesini art\u0131raca\u011f\u0131 hem de T\u00fcrkiye\u2019nin HIV kaynakl\u0131 sa\u011fl\u0131k y\u00fck\u00fcn\u00fc azaltaca\u011f\u0131 ifade edildi.<\/p>\n\n\n\n<p><a><strong>HIV\u2019de Bilgi Eksikli\u011fi ve Erken Tan\u0131n\u0131n \u00d6nemi<\/strong><\/a><\/p>\n\n\n\n<p>1980\u2019lerde ortaya \u00e7\u0131kan HIV enfeksiyonu, t\u0131ptaki geli\u015fmeler sayesinde bug\u00fcn y\u00f6netilebilir bir kronik enfeksiyon haline geldi. Ancak buna ra\u011fmen toplumda HIV enfeksiyonu ve tedavi edilmedi\u011finde ilerleyerek yol a\u00e7abilece\u011fi AIDS hakk\u0131ndaki bilgi eksikli\u011fi s\u00fcr\u00fcyor. Bu durum, ki\u015filerin test yapt\u0131rma konusunda \u00e7ekingen davranmas\u0131na, dolay\u0131s\u0131yla hem tan\u0131n\u0131n ge\u00e7 konmas\u0131na hem de enfeksiyonun yay\u0131lmas\u0131na yol a\u00e7\u0131yor. HIV\/AIDS alan\u0131nda yenilik\u00e7i tedaviler geli\u015ftiren Gilead ise yakla\u015f\u0131k k\u0131rk y\u0131ld\u0131r k\u00fcresel \u00e7apta HIV ile m\u00fccadelede bilimsel inovasyonun \u00f6nc\u00fcs\u00fc olarak \u00e7al\u0131\u015f\u0131yor. <a>\u015eirket, hekim dernekleri, \u00f6zne dernekleri ve di\u011fer sivil toplum kurulu\u015flar\u0131yla i\u015f birli\u011fi i\u00e7inde y\u00fcr\u00fctt\u00fc\u011f\u00fc fark\u0131ndal\u0131k kampanyalar\u0131yla son \u00fc\u00e7 y\u0131ld\u0131r HIV Testi Fark\u0131ndal\u0131\u011f\u0131 Haftas\u0131\u2019n\u0131n hayata ge\u00e7irilmesine \u00f6nc\u00fcl\u00fck ediyor.<\/a><\/p>\n\n\n\n<p>Gilead T\u00fcrkiye Genel M\u00fcd\u00fcr\u00fc Deepshikha Kiyawat, konu\u015fmas\u0131nda testin \u00f6nemine dikkat \u00e7ekerek \u015funlar\u0131 s\u00f6yledi: \u201cHer bireyin korkmadan, damgalanmadan ve belirsizlik ya\u015famadan sa\u011fl\u0131\u011f\u0131yla ilgili ad\u0131m atabilmesi temel bir hakt\u0131r. Erken tan\u0131 do\u011fru tedaviye eri\u015fimin ve HIV ile \u00f6zg\u00fcr bir ya\u015fam\u0131n \u00f6n\u00fcn\u00fc a\u00e7ar. Ancak, HIV enfeksiyonu hala \u00f6nemli bir halk sa\u011fl\u0131\u011f\u0131 sorunu olmaya devam ediyor. Bug\u00fcn biliyoruz ki, HIV ile ilgili zorluklar\u0131m\u0131z t\u0131bbi de\u011fil; bilgi eksikli\u011fi, \u00f6n yarg\u0131lar, sessizlik ve duygusal bariyerler. Bu nedenle doktorlar\u0131m\u0131z, \u00f6zne dernekleri ve di\u011fer sivil toplum kurulu\u015flar\u0131 ile \u00e7al\u0131\u015f\u0131yoruz ve hep birlikte \u2018HIV H\u0130\u00c7 Zor De\u011fil\u2019 diyerek g\u00fcvenli test yapt\u0131rman\u0131n yollar\u0131na dair fark\u0131ndal\u0131\u011f\u0131 art\u0131rmay\u0131 ama\u00e7l\u0131yoruz.<\/p>\n\n\n\n<p>Gilead olarak bug\u00fcne kadar 30.000\u2019den fazla \u00fccretsiz ve anonim HIV testi ba\u011f\u0131\u015f\u0131yla erken tan\u0131 s\u00fcrecine katk\u0131 sa\u011flad\u0131k. T\u00fcrkiye\u2019de y\u00fcr\u00fctt\u00fc\u011f\u00fcm\u00fcz ara\u015ft\u0131rma hibe program\u0131 kapsam\u0131nda HIV, hepatit ve di\u011fer enfeksiyon hastal\u0131klar\u0131 alan\u0131nda toplam 2 milyon ABD dolar\u0131na ula\u015fan 84 projeye destek verdik. \u00d6n\u00fcm\u00fczdeki d\u00f6nemde yeni inisiyatifler ile hep birlikte HIV epidemisini sonland\u0131rmak i\u00e7in \u00e7al\u0131\u015fmaya devam edece\u011fiz.\u201d&nbsp;<\/p>\n\n\n\n<p><strong>HIV ALANINDA UZMAN HEK\u0130M VE DERNEKLERDEN MESAJLAR<\/strong><\/p>\n\n\n\n<p><strong>Prof. Dr. Serhat \u00dcnal (HAKED- HIV AIDS Korunma ve E\u011fitim Derne\u011fi)<\/strong><\/p>\n\n\n\n<p>\u201cHIV ile m\u00fccadelede en kritik ad\u0131m, toplumda do\u011fru bilgiyle fark\u0131ndal\u0131\u011f\u0131n art\u0131r\u0131lmas\u0131d\u0131r. Kilit gruplarda d\u00fczenli tarama, erken tan\u0131 ve tedaviye y\u00f6nlendirme hem bireysel sa\u011fl\u0131\u011f\u0131 korur hem de toplumdaki genel HIV y\u00fck\u00fcn\u00fc azalt\u0131r. T\u0131p alan\u0131ndaki geli\u015fmeler sayesinde HIV art\u0131k y\u00f6netilebilir bir enfeksiyondur; ancak damgalama ve bilgi eksikli\u011fi erken tan\u0131n\u0131n \u00f6n\u00fcndeki en b\u00fcy\u00fck engel olmaya devam ediyor.\u201d<\/p>\n\n\n\n<p><strong>Prof. Dr. H\u00fcsn\u00fc Pulluk\u00e7u (EKMUD- T\u00fcrkiye Enfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Uzmanl\u0131k Derne\u011fi)<\/strong><\/p>\n\n\n\n<p>\u201cToplumda HIV konusunda halen \u00e7ok say\u0131da yanl\u0131\u015f bilgi bulunuyor. HIV g\u00fcndelik temasla, sar\u0131lmakla, ayn\u0131 ortam\u0131 payla\u015fmakla ya da ortak e\u015fya kullan\u0131m\u0131yla bula\u015fmaz. En etkili korunma y\u00f6ntemleri d\u00fczenli kondom kullan\u0131m\u0131, d\u00fczenli test ve T\u00d6P (Temas \u00d6ncesi Profilaksi) &nbsp;gibi modern korunma yakla\u015f\u0131mlar\u0131d\u0131r. Yanl\u0131\u015f kan\u0131lar damgalamay\u0131 besledi\u011fi i\u00e7in, bilimsel bilgiye dayal\u0131 ileti\u015fim ve sa\u011fl\u0131k okuryazarl\u0131\u011f\u0131n\u0131n geli\u015ftirilmesi b\u00fcy\u00fck \u00f6nem ta\u015f\u0131yor.\u201d<\/p>\n\n\n\n<p><strong>Prof. Dr. Ye\u015fim Ta\u015fova (G\u00dcN\u0130DER- G\u00fcneydo\u011fu N\u00f6roloji \u0130nfeksiyon Derne\u011fi)<\/strong><\/p>\n\n\n\n<p>\u201cHIV t\u00fcm ki\u015fileri etkileyebilir ancak toplumsal cinsiyet e\u015fitsizlikleri ve bilgiye eri\u015fimdeki s\u0131n\u0131rl\u0131l\u0131klar kad\u0131nlar\u0131 ve gen\u00e7 k\u0131zlar\u0131 daha k\u0131r\u0131lgan hale getiriyor. Kad\u0131nlarda tan\u0131 gecikmesi s\u0131k g\u00f6r\u00fclen bir durum ve bunun en \u00f6nemli sebepleri damgalanma kayg\u0131s\u0131 ve sa\u011fl\u0131k hizmetine eri\u015fimde zorluklar. Oysa gebelikte HIV do\u011fru y\u00f6netildi\u011finde bebe\u011fe bula\u015f neredeyse tamamen \u00f6nlenebilir. Erken tan\u0131 hem kad\u0131nlar hem \u00e7ocuklar i\u00e7in hayat kurtar\u0131c\u0131d\u0131r.\u201d<\/p>\n\n\n\n<p><strong>Prof. Dr. \u00d6mer Fehmi Tabak (HIVEND- HIV Enfeksiyonu Derne\u011fi)<\/strong><\/p>\n\n\n\n<p>\u201cHIV bug\u00fcn epidemiyolojik olarak hala kontrol alt\u0131na al\u0131nmas\u0131 gereken bir halk sa\u011fl\u0131\u011f\u0131 sorunu olmaya devam ediyor. Bunun i\u00e7in en h\u0131zl\u0131 ve etkili strateji testin yayg\u0131nla\u015ft\u0131r\u0131lmas\u0131, erken tan\u0131 ve tedaviye eri\u015fimin g\u00fc\u00e7lendirilmesi. G\u00fcncel tedaviler sayesinde HIV kontrol alt\u0131na al\u0131nabilir bir enfeksiyon haline geldi ve bu tedavilere eri\u015fim, halk sa\u011fl\u0131\u011f\u0131 a\u00e7\u0131s\u0131ndan en \u00f6nemli ara\u00e7lardan biri.\u201d<\/p>\n\n\n\n<p><strong>Prof. Dr. Ay\u015fe Deniz G\u00f6kengin (AIDS ve Cinsel Yolla Bula\u015fan Hastal\u0131klar Derne\u011fi)<\/strong><\/p>\n\n\n\n<p>\u201cHIV Testi \u00fclkemizde t\u00fcm sa\u011fl\u0131k kurulu\u015flar\u0131nda genel sa\u011fl\u0131k sigortas\u0131 kapsam\u0131nda olan ki\u015filer i\u00e7in \u00fccretsizdir ve g\u00fcvenle yap\u0131labilir. Sonu\u00e7lar\u0131n gizlili\u011fi yasal olarak korunur. Ayr\u0131ca ki\u015fi istedi\u011fi takdirde, G\u00f6n\u00fcll\u00fc Dan\u0131\u015fmanl\u0131k ve Test Merkezleri\u2019nde kimlik bilgilerini vermeden ve sa\u011fl\u0131k sigortas\u0131 kapsam\u0131nda olmasa da \u00fccretsiz olarak test yapt\u0131rabilir. Teste kolay eri\u015fim ve gizlili\u011fin korunmas\u0131 erken tan\u0131n\u0131n \u00f6n\u00fcn\u00fc a\u00e7\u0131yor ve toplum sa\u011fl\u0131\u011f\u0131na katk\u0131 sa\u011fl\u0131yor.\u201d<\/p>\n\n\n\n<p><strong>Prof. Dr. Asuman \u0130nan (KL\u0130M\u0130K- T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Derne\u011fi)<\/strong><\/p>\n\n\n\n<p>\u201cBilimsel olarak bug\u00fcn biliyoruz ki tedavi ile viral y\u00fck bask\u0131land\u0131\u011f\u0131nda HIV cinsel yolla bula\u015fmaz; bunu B=B yani \u2018Belirlenemeyen = Bula\u015ft\u0131rmayan\u2019 \u015feklinde ifade ediyoruz. Bu bilgi hem damgalamay\u0131 azaltmak hem de HIV ile ya\u015fayan ki\u015filerin ya\u015fam kalitesini art\u0131rmak a\u00e7\u0131s\u0131ndan kritik \u00f6neme sahip. Sa\u011fl\u0131k hizmetine erken ba\u015fvuru ve tedaviye ba\u011fl\u0131l\u0131k sayesinde HIV ile ya\u015fayan ki\u015filerin uzun, sa\u011fl\u0131kl\u0131 ve \u00fcretken bir ya\u015fam s\u00fcrmesi m\u00fcmk\u00fcnd\u00fcr.\u201d<\/p>\n\n\n\n<p><strong>\u00c7i\u011fdem \u015eim\u015fek (Pozitif-iz Derne\u011fi)<\/strong><\/p>\n\n\n\n<p>\u201cTan\u0131 sonras\u0131 en b\u00fcy\u00fck ihtiya\u00e7 g\u00fcvenilir bilgi, psiko-sosyal destek ve mahremiyettir. \u0130lk tan\u0131 \u00e7o\u011fu zaman korku, belirsizlik ve yanl\u0131\u015f bilgilerle kar\u015f\u0131land\u0131\u011f\u0131 i\u00e7in dan\u0131\u015fmanl\u0131k ve dayan\u0131\u015fma b\u00fcy\u00fck \u00f6nem ta\u015f\u0131yor. Dernekler olarak ki\u015filerin tedaviye eri\u015fimini kolayla\u015ft\u0131ran, hukuki ve sosyal destek sa\u011flayan, yanl\u0131\u015f bilgilerin \u00f6n\u00fcne ge\u00e7en bir yol arkada\u015fl\u0131\u011f\u0131 sunuyoruz. Do\u011fru bilgiye eri\u015fim damgalamay\u0131 azaltman\u0131n en g\u00fc\u00e7l\u00fc yolu.\u201d<\/p>\n\n\n\n<p><strong>Nurcan M\u00fcft\u00fco\u011flu (TAPV- T\u00fcrkiye Aile Sa\u011fl\u0131\u011f\u0131 Planlamas\u0131 Vakf\u0131)<\/strong><\/p>\n\n\n\n<p>\u201cGen\u00e7ler bilgiye \u00e7ok h\u0131zl\u0131 ula\u015fsa da g\u00fcvenilir ve bilimsel bilgiye eri\u015fimleri s\u0131n\u0131rl\u0131 kalabiliyor. Cinsellik e\u011fitiminin \u00e7o\u011fu zaman tabu olmas\u0131 riskleri art\u0131r\u0131yor. Okullarda kapsaml\u0131 sa\u011fl\u0131k okuryazarl\u0131\u011f\u0131 programlar\u0131, gen\u00e7 dostu hizmet modelleri ve sosyal medya \u00fczerinden bilim temelli bilgilendirme hem gen\u00e7lerin sa\u011fl\u0131\u011f\u0131n\u0131 g\u00fc\u00e7lendirir hem de uzun vadede HIV epidemisinin seyrini olumlu y\u00f6nde etkiler.\u201d<\/p>\n\n\n\n<p><strong>Ya\u011fmur \u015eeno\u011fuz (Pozitif Ya\u015fam Derne\u011fi)<\/strong><\/p>\n\n\n\n<p>\u201cDamgalama ne yaz\u0131k ki h\u00e2l\u00e2 \u00e7ok yayg\u0131n ve bu durum i\u015f hayat\u0131ndan sosyal \u00e7evreye, sa\u011fl\u0131k hizmetlerine eri\u015fimden g\u00fcndelik hayata kadar pek \u00e7ok alanda etkisini g\u00f6steriyor. Bu stigman\u0131n temelinde HIV\u2019e ili\u015fkin yanl\u0131\u015f bilgiler, \u00f6n yarg\u0131lar ve toplumsal tabular yat\u0131yor. Bilim temelli ileti\u015fim, medyan\u0131n do\u011fru dili, topluma ve sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131na y\u00f6nelik e\u011fitimler damgalamay\u0131 azaltman\u0131n anahtar\u0131. B=B mesaj\u0131n\u0131n yayg\u0131nla\u015fmas\u0131 ise hem ki\u015filerin \u00f6zg\u00fcvenini art\u0131r\u0131yor hem de toplumdaki \u00f6n yarg\u0131lar\u0131 k\u0131r\u0131yor.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>1 Aral\u0131k D\u00fcnya AIDS G\u00fcn\u00fc \u00f6ncesinde Gilead T\u00fcrkiye\u2019nin ev sahipli\u011finde d\u00fczenlenen \u201cHIV Zor De\u011fil \/ H\u0130\u00c7 Zor De\u011fil\u201d temal\u0131 bas\u0131n toplant\u0131s\u0131nda uzman hekimler ve sivil toplum temsilcileri bir araya gelerek erken tan\u0131n\u0131n hayati \u00f6nemine dikkat \u00e7ekti. Toplant\u0131da, HIV testine eri\u015fimin kolayla\u015ft\u0131r\u0131lmas\u0131, damgalaman\u0131n azalt\u0131lmas\u0131 ve toplumda a\u00e7\u0131k diyalo\u011fun g\u00fc\u00e7lendirilmesi gerekti\u011fi vurguland\u0131. Payda\u015flar, d\u00fczenli testlerin yayg\u0131nla\u015fmas\u0131n\u0131n hem ki\u015filerin ya\u015fam kalitesini art\u0131raca\u011f\u0131 hem de T\u00fcrkiye\u2019nin HIV kaynakl\u0131 sa\u011fl\u0131k y\u00fck\u00fcn\u00fc azaltaca\u011f\u0131 mesaj\u0131n\u0131 verdi.<\/p>\n","protected":false},"author":1,"featured_media":4430,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,42],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4429"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4429"}],"version-history":[{"count":1,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4429\/revisions"}],"predecessor-version":[{"id":4431,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4429\/revisions\/4431"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/4430"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}